Contrasting effects of vortioxetine and paroxetine on pineal gland biochemistry in a tryptophan-depletion model of depression in female rats

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):499-502. doi: 10.1016/j.pnpbp.2017.08.008. Epub 2017 Aug 10.

Abstract

We studied the effects of the multi-modal antidepressant, vortioxetine and the SSRI, paroxetine on pineal melatonin and monoamine synthesis in a sub-chronic tryptophan (TRP) depletion model of depression based on a low TRP diet. Female Sprague-Dawley rats were randomised to groups a) control, b) low TRP diet, c) low TRP diet+paroxetine and d) low TRP diet+vortioxetine. Vortioxetine was administered via the diet (0.76mg/kg of food weight) and paroxetine via drinking water (10mg/kg/day) for 14days. Both drugs resulted in SERT occupancies >90%. Vortioxetine significantly reversed TRP depletion-induced reductions of pineal melatonin and serotonin (5-HT) and significantly increased pineal noradrenaline NA. Paroxetine did none of these things. Other studies suggest pineal melatonin synthesis may involve N-methyl-d-aspartate (NMDA) receptors and glutamatergic modulation. Here observed changes may be mediated via vortioxetine's strong 5-HT reuptake blocking action together with possible additional effects on glutamate neurotransmission in the pineal via NMDA receptor-modulation and possibly with added impetus from increased NA output.

Publication types

  • Comparative Study

MeSH terms

  • Administration, Oral
  • Animals
  • Antidepressive Agents, Second-Generation / pharmacology
  • Depressive Disorder / drug therapy*
  • Depressive Disorder / metabolism
  • Disease Models, Animal
  • Female
  • Glutamic Acid / metabolism
  • Melatonin / metabolism
  • Norepinephrine / metabolism
  • Paroxetine / pharmacology*
  • Pineal Gland / drug effects*
  • Pineal Gland / metabolism
  • Piperazines / pharmacology*
  • RNA-Binding Proteins / metabolism
  • Random Allocation
  • Rats, Sprague-Dawley
  • Receptors, N-Methyl-D-Aspartate / metabolism
  • Selective Serotonin Reuptake Inhibitors / pharmacology*
  • Serotonin / metabolism
  • Sulfides / pharmacology*
  • Tryptophan / deficiency
  • Vortioxetine

Substances

  • Antidepressive Agents, Second-Generation
  • Piperazines
  • RNA-Binding Proteins
  • Receptors, N-Methyl-D-Aspartate
  • Serotonin Uptake Inhibitors
  • Sert1 protein, rat
  • Sulfides
  • Serotonin
  • Glutamic Acid
  • Vortioxetine
  • Paroxetine
  • Tryptophan
  • Melatonin
  • Norepinephrine